Related references
Note: Only part of the references are listed.Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women
Robert B. Belshe et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Better Neutralization of Herpes Simplex Virus Type 1 (HSV-1) Than HSV-2 by Antibody From Recipients of GlaxoSmithKline HSV-2 Glycoprotein D2 Subunit Vaccine
Sita Awasthi et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2014)
The Herpes Virus Fc Receptor gE-gI Mediates Antibody Bipolar Bridging to Clear Viral Antigens from the Cell Surface
Blaise Ndjamen et al.
PLOS PATHOGENS (2014)
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection
Mark Shlapobersky et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2012)
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Robert B. Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge
Christopher S. Morello et al.
VACCINE (2012)
Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection
Elizabeth Tronstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Persistent Genital Herpes Simplex Virus-2 Shedding Years Following the First Clinical Episode
Warren Phipps et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Development of a Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) Recombinant Viral Vaccine against HSV-2 Infection in Mice
Natalie V. Akhrameyeva et al.
JOURNAL OF VIROLOGY (2011)
The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular Cytotoxicity In Vivo
John M. Lubinski et al.
JOURNAL OF VIROLOGY (2011)
Immunization with Herpes Simplex Virus 2 (HSV-2) Genes plus Inactivated HSV-2 Is Highly Protective against Acute and Recurrent HSV-2 Disease
Christopher S. Morello et al.
JOURNAL OF VIROLOGY (2011)
Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2011)
A Live-Attenuated HSV-2 ICP0- Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine
William P. Halford et al.
PLOS ONE (2011)
A mucosal vaccination approach for herpes simplex virus type 2
Rebecca S. Tirabassi et al.
VACCINE (2011)
Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig
David I. Bernstein et al.
VACCINE (2011)
Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro
Mark R. Harris et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons
Fushan Wang et al.
VIROLOGY (2010)
Protection from Herpes Simplex Virus (HSV)-2 Infection with Replication-Defective HSV-2 or Glycoprotein D2 Vaccines in HSV-1-Seropositive and HSV-1-Seronegative Guinea Pigs
Yo Hoshino et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Herpes Simplex Virus Type 1 Glycoprotein E Mediates Retrograde Spread from Epithelial Cells to Neurites
Helen M. McGraw et al.
JOURNAL OF VIROLOGY (2009)
Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine
Sita Awasthi et al.
VACCINE (2009)
Correlates of vaccine-induced immunity
Stanley A. Plotkin
CLINICAL INFECTIOUS DISEASES (2008)
Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes
Sara Tengvall et al.
JOURNAL OF VIROLOGY (2006)
Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging
Elizabeth R. Sprague et al.
PLOS BIOLOGY (2006)
Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody
LM Hook et al.
JOURNAL OF VIROLOGY (2006)
Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function
TM Cairns et al.
JOURNAL OF VIROLOGY (2006)
Herpes simplex virus type 1 glycoprotein E is required for axonal localization of capsid, tegument, and membrane glycoproteins
FS Wang et al.
JOURNAL OF VIROLOGY (2005)
Synergy tests by E test and checkerboard methods of antimicrobial combinations against Brucella melitensis
G Orhan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor
XQ Lin et al.
JOURNAL OF VIROLOGY (2004)
The complement system in regulation of adaptive immunity
MC Carroll
NATURE IMMUNOLOGY (2004)
The potential of immunostimulatory CpG DNA for inducing immunity against genital herpes: opportunities and challenges
AM Harandi
JOURNAL OF CLINICAL VIROLOGY (2004)
The complement system in B cell regulation
MC Carroll
MOLECULAR IMMUNOLOGY (2004)
Blocking immune evasion as a novel approach for prevention and treatment of herpes simplex virus infection
KA Judson et al.
JOURNAL OF VIROLOGY (2003)
Glycoprotein-D-adjuvant vaccine to prevent genital herpes
LR Stanberry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Novel mechanism of antibody-independent complement neutralization of herpes simplex virus type 1
HM Friedman et al.
JOURNAL OF IMMUNOLOGY (2000)
Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease
CE Saldanha et al.
JOURNAL OF VIROLOGY (2000)
Effects of androstenedione in young men
R Palusinski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
